43
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Comparison of the biochemical effects of testosterone and estrogen on bone markers in surgically menopausal women

, , &
Pages 382-387 | Published online: 05 Aug 2009

References

  • Lindsay R, Hart DM, Forrest C, et al. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980; 2: 1151–4
  • Genant HK, Cann CE, Ettinger B, et al. Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982; 97: 699–705
  • Michaëlsson K, Baron JA, Farahmand BY, et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. Br Med J 1998; 316: 1858–63
  • Wahab M, Ballard P, Purdie DW, et al. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy. Br J Obstet Gynecol 1997; 104: 728–31
  • Judd HL, Judd GE, Lucas WE, et al. Endocrine function of postmenopausal ovary: concentration of androgen and oestrogens in ovarian and peripheral vein blood. J Clin Endocrin Met 1974; 39: 1020–3
  • Colvard DS, Eriksen EF, Keeting PE, et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natn Acad Sci 1989; 86: 854–75
  • Francis R, Peacock M, Aaron JE, et al. Osteoporosis in hypogonadal men. Role of decreased plasma 1,25 dihydroxy vitamin D, calcium malabsorption, and low bone formation. Bone 1986; 7: 261–8
  • Davidson BJ, Ross RK, Pagannini-Hill, et al. Total and free oestrogens and androgens in postmenopausal women with hip fractures. J Clin Endocri Metab 1982; 54: 115–20
  • Watts NB, Notelovitz M, Timmons TC, et al. Comparison of oral oestrogens plus androgen on bone mineral density, menopausal symptoms and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995; 85: 529–37
  • Davis SR, McCloud P, Strauss BJG, et al. Testosterone enhances oestradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995; 21: 227–36
  • Taylor AK, Lueken SA, Libanati C, et al. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 1994; 20: 589–607
  • Risteli J, Elomaa I, Niemi S, et al. Radioimmunoassay for the pyridoline cross-linked carboxy terminal telopeptide of type 1 collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635–40
  • Melkko J, Niemi S, Risteli J. Radioimmunoassay of the carboxy terminal propeptide of human type 1 procollagen. Clin Chem 1990; 36: 1328–32
  • Eriksen EF, Charles P, Melsen F, et al. Serum markers of type 1 collagen formation and degradation: correlation to bone histmorphometry. J Bone Miner Res 1993; 8: 127–32
  • Charles P, Mosekilde L, Risteli L, et al. Assessment of bone remodelling using biochemical indicators of type 1 collagen synthesis and degradation: relation to calcium kinetics. Bone Min 1994; 24: 81–94
  • Eriksen EF, Kassem M, Brixen K. Growth Hormone and insulin-like growth factors as anabolic therapies for osteoprosis. Horm Res 1994; 40: 95–8
  • Thorn MH, Studd JWW. Hormone implantation. Br Med J 1980; 1: 848–50
  • Carter GD, Holland SM, Alaghband-Zadeh J, et al. Investigation of hirsutism: testosterone is not enough. Ann Clin Biochem 1983; 20: 262–3
  • Garnett T, Studd JWW, Watson N, et al. The effects of plasma oestradiol levels on increases in vertebral and femoral bone density following therapy with oestradiol and oestradiol with testosterone implants. Obstet Gynecol 1992; 79: 968–72
  • Barlow DH, Abdalla HI, Roberts ADG, et al. Long-term hormone implant therapy: Hormonal and clinical effects. Obstet Gynecol 1986; 67: 321–5
  • Raisz LG, Wiita B, Artis A, et al. Comparson of the effects of oestrogen alone and oestrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endoc Metab 1996; 81: 37–43
  • Studd JWW, Savvas M, Watson NR, et al. The relationship between plasma oestradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants. Am J Obstet Gynecol 1990; 163: 1474–9
  • Casson PR, Elkind-Hirsch K, Buster JE, et al. Effect of postmenopausal oestrogen replacement on circulating androgens. Obstet Gynecol 1997; 90: 995–8
  • Khosla S, Melton J, Atkinson E, et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable oestrogen. J Clin Endocrinol Metab 1998; 83: 2266–73
  • Smith EP, Boyd J, Frank GR, et al. Oestrogen resistance caused by a mutation in the oestrogen-receptor in a man. N Engl J Med 1994; 331: 1056–61
  • Carani C, Qin K, Simoni M, et al. Effect of testosterone and oestradiol in a man with aromatase deficiency. N Engl J Med 1997; 337: 91–5
  • Morishima A, Grumbach MM, Bilezikian JP. Abstract 96. Oestrogen markedly increases bone mass in an oestrogen deficient young man with aromatase deficiency. J Bone Miner Res, 12S: S126
  • Sands RH, Studd JWW. Exogenous androgens in postmenopausal women. Am J Med 1995; 98: 76–7S
  • Sherwin BB, Gelfand MM. Differential symptom response to parenteral oestrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985; 151: 153–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.